Collagen, Type I, Alpha-2

Alternative Names

  • COL1A2
  • Collagen of Skin, Tendon, and Bone, Alpha-2 Chain
Back to search Result
OMIM Number

120160

NCBI Gene ID

1278

Uniprot ID

P08123

Length

36,333 bases

No. of Exons

52

No. of isoforms

1

Protein Name

Collagen alpha-2(I) chain

Molecular Mass

129314 Da

Amino Acid Count

1366

Genomic Location

chr7:94,394,894-94,431,226

Gene Map Locus
7q21.3

Description

This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [From RefSeq]

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_000089.4:c.1378G>ASaudi ArabiaNC_000007.14:g.94412095G>APathogenicLikely Pathogenic, PathogenicOsteogenesis Imperfecta, Type IVNG_007405.1:g.22535G>A; NM_000089.4:c.1378G>A; NP_000080.2:p.Gly460Ser72658118526895
NM_000089.4:c.1747G>CSaudi ArabiaNC_000007.14:g.94415253G>CLikely PathogenicOsteogenesis Imperfecta, Type IING_007405.1:g.25693G>C; NM_000089.4:c.1747G>C; NP_000080.2:p.Gly583Arg
NM_000089.4:c.279+1G>ALebanonNC_000007.14:g.94401621G>APathogenicPathogenicEhlers-Danlos Syndrome, Arthrochalasia Type, 2NG_007405.1:g.12061G>A; NM_000089.4:c.279+1G>A6739823417251
NM_000089.4:c.2873G>AEgyptNC_000007.14:g.94425787G>APathogenicOsteogenesis Imperfecta, Type IVNG_007405.1:g.36227G>A; NM_000089.4:c.2873G>A; NP_000080.2:p.Gly958Asp
NM_000089.4:c.292C>TSaudi ArabiaNC_000007.14:g.94404568C>TUncertain SignificanceUncertain SignificanceNG_007405.1:g.15008C>T; NM_000089.4:c.292C>T; NP_000080.2:p.Pro98Ser765868569580339
NM_000089.4:c.3043G>ASaudi ArabiaNC_000007.14:g.94426468G>APathogenicOsteogenesis Imperfecta, Type IVNG_007405.1:g.36908G>A; NM_000089.4:c.3043G>A; NP_000080.2:p.Gly1015Arg72659320
NM_000089.4:c.821G>ASaudi ArabiaNC_000007.14:g.94409350G>APathogenicPathogenicOsteogenesis Imperfecta, Type IVNG_007405.1:g.19790G>A; NM_000089.4:c.821G>A; NP_000080.2:p.Gly274Asp676759511071305
© CAGS 2024. All rights reserved.